| [9] |
Fujii T, Nojima T H, Satoh S, et al. Cytokine and immunogenetic profiles in Japanese patients with adult Still’s disease. Association with chronic articular disease.[J]. Rheumatology, 2001, 40(12):1398–1404.
|
| [10] |
Joung CI, Lee HS, Lee SW, et al. Association between HLA-DR B1 and clinical features of adult onset Still’s disease in Korea.[J]. Clin Exp Rheumatol, 2003, 21(4):489–492.
|
| [11] |
Sugiura T, Maeno N, Kawaguchi Y, et al. A promoter haplotype of the interleukin-18 gene is associated with juvenile idiopathic arthritis in the Japanese population[J]. Arthrit Res Ther, 2006, 8(3):R60.
|
| [1] |
Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still’s disease[J]. J Rheumatol, 1992, 19(3):424–430.
|
| [2] |
Cush JJ, Medsger TA, Christy WC, et al. Adult-onset Still’s disease[J]. Arthritis Rheum, 1987, 30(2):186–194.
|
| [3] |
Reginato AJ, Schumacher HR, Baker DG, et al. Adult onset Still’s disease: experience in 23 patients andliterature review with emphasis on organ failure[J]. Semin Arthritis Rheum, 1987, 17(1):39–57.
|
| [4] |
Masson C, Le Loet X, Liote F, et al. Comparative study of 6 types of criteria in adult Still’s disease[J]. J Rheumatol, 1996, 23(3):495–497.
|
| [5] |
Jiang L, Wang Z, Dai X, et al. Evaluation of clinical measures and different criteria for diagnosis of adult- onset Still’s disease in a Chinese population[J]. J Rheumatol, 2011, 38(4):741–746.
|
| [6] |
Gerfaud-Valentin M, Maucort-Boulch D, Hot A, et al. Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients[J]. Medicine, 2014, 93(2):91–99.
|
| [12] |
Wang FF, Huang XF, Shen N, et al. A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still’s disease[J]. Arthrit Res Ther, 2013, 15(3):R65.
|
| [13] |
Komiya A, Matsui T, Nogi S, et al. Neutrophil CD64 is upregulated in patients with active adult-onset Still’s disease[J]. Scand J Rheumatol, 2012, 41(2):156–158.
|
| [14] |
Jung SY, Park YB, Ha YJ, et al. Serum calprotectin as a marker for disease activity and severity in adult- onset Still’s disease[J]. J Rheumatol, 2010, 37(5):1029–1034.
|
| [15] |
Chen DY, Lan JL, Lin FJ, et al. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still’s disease[J]. Arthritis Rheum, 2005, 53(3):320–327.
|
| [16] |
Choi JH, Suh CH, Lee YM, et al. Serum cytokine profiles in patients with adult onset Still’s disease[J]. J Rheumatol, 2003, 30(11):2422–2427.
|
| [17] |
Kontzias A, Efthimiou P. Adult-onset Still’s disease[J]. Drugs, 2008, 68(3):319–337.
|
| [18] |
Mavragani CP, Spyridakis EG, Koutsilieris M. Adult-onset Still’s disease: from pathophysiology to targeted therapies[J]. Internatil J Inflam, 2012, 2012:879020.
|
| [19] |
Bagnari V, Colina M, Ciancio G, et al. Adult-onset Still’s disease[J]. Rheumatol Int, 2010, 30(7):855–862.
|
| [20] |
Chen DY, Hsieh TY, Hsieh CW, et al. Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still’s disease[J]. Arthritis Rheum, 2007, 57(8):1530–1538.
|
| [21] |
Chen DY, Chen YM, Lan JL, et al. Potential role of Th17 cells in the pathogenesis of adult-onset Still’s disease[J]. Rheumatology, 2010: 49(12):2305–2312.
|
| [22] |
Chen DY, Chen YM, Chen HH, et al. The associations of circulating CD4+ CD25high regulatory T cells and TGF-β with disease activity and clinical course in patients with adult-onset Still’s disease[J]. Connect Tissue Res, 2010, 51(5):370–377.
|
| [23] |
Gilbert DN. Use of plasma procalcitonin levels as an adjunct to clinical microbiology[J]. J Clin Microbiol, 2010, 48(7):2325–2329.
|
| [24] |
Mehta B, Efthimiou P. Ferritin in adult-onset Still’s disease: just a useful innocent bystander?[J]. Int J Inflam, 2012, 2012:254858.
|
| [25] |
Owlia MB, Mehrpoor G. Adult-onset Still’s disease: a review[J]. Indian J Med Sci, 2009, 63(5):207–221.
|
| [26] |
Fautrel B, Le Moël G, Saint-Marcoux B, et al. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still’s disease[J]. J Rheumatol, 2001, 28(2):322–329.
|
| [27] |
Iliou C, Papagoras C, Tsifetaki N, et al. Adult-onset Still’s disease: clinical, serological and therapeutic considerations[J]. Clin Exp Rheumatol, 2012, 31(1):47–52.
|
| [28] |
Kwok JS, Wong PC, Luk MC, et al. Use of glycosylated ferritin assay to aid the diagnosis of adult-onset Still’s disease: a local laboratory experience in Hong Kong[J]. RheumatolInt, 2012, 32(8):2583–2584.
|
| [29] |
Novak S, Anic F, Luke-Vrbanic' TS. Extremely high serum ferritin levels as a main diagnostic tool of adult-onset Still’s disease[J]. Rheumatol Int, 2012, 32(4):1091–1094.
|
| [30] |
Jung SY, Park YB, Ha YJ, et al. Serum calprotectin as a marker for disease activity and severity in adult-onset Still’s disease[J]. J Rheumatol, 2010, 37(5):1029–1034.
|
| [31] |
Kalyoncu U, Buyukasık Y, Akdogan A, et al. Increased serum vitamin B12 levels are associated with adult- onset Still’s disease with reactive macrophage activation syndrome[J]. Joint Bone Spine, 2010, 77(2):131–134.
|
| [32] |
Colafrancesco S, Priori R, Alessandri C, et al. IL-18 serum level in adult onset Still’s disease: A marker of disease activity[J]. Int J Inflam, 2012, 2012:156890.
|
| [7] |
Sampalis JS, Esdaile JM, Medsger TA, et al. A controlled study of the long-term prognosis of adult Still’s disease[J]. Am J Med, 1995, 98(4):384–388.
|
| [8] |
Pouchot J, Sampalis JS, Beaudet F, et al. Adult Still’s disease: manifestations, disease course, and outcome in 62 patients[J]. Medicine, 1991, 70(2):118–136.
|
| [33] |
Roberta P, Serena C, Cristiano A, et al. Interleukin 18: a biomarker for differential diagnosis between adult-onset Still’s disease and sepsis.[J]. J Rheumatol, 2014, 41(6):1118–1123.
|
| [34] |
Gaetano C, Stefania R, Alberto M, et al. Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype.[J]. Trends Immunol, 2011, 32(6):241–247.
|